Analyst Price Targets — CDLX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 8, 2026 12:53 pm | — | Lake Street | $1.00 | $0.74 | TheFly | Cardlytics price target lowered to $1 from $1.25 at Lake Street |
| March 6, 2026 1:42 pm | Mark Mahaney | Evercore ISI | $1.00 | $0.77 | StreetInsider | Cardlytics (CDLX) PT Lowered to $1 at Evercore ISI, removed from TAP Underperform List |
| March 13, 2025 12:42 pm | — | Lake Street | $3.00 | $2.07 | TheFly | Cardlytics price target lowered to $3 from $5 at Lake Street |
| October 11, 2024 7:25 am | Mark Mahaney | Evercore ISI | $4.00 | $3.22 | TheFly | Cardlytics initiated with an In Line at Evercore ISI |
| August 16, 2024 8:46 am | Luke Horton | Northland Securities | $5.00 | $3.75 | TheFly | Cardlytics downgraded to Market Perform from Outperform at Northland |
| August 15, 2024 6:07 am | Omar Dessouky | Bank of America Securities | $3.50 | $3.69 | TheFly | Cardlytics downgraded to Underperform from Neutral at BofA |
| August 8, 2024 8:58 am | Jason Kreyer | Craig-Hallum | $4.00 | $2.96 | TheFly | Craig-Hallum downgrades Cardlytics to Hold following CEO news, Q3 guide |
| August 8, 2024 8:39 am | Luke Horton | Northland Securities | $7.00 | $6.90 | TheFly | Cardlytics price target lowered to $7 from $14 at Northland |
| June 18, 2024 7:50 am | Luke Horton | Northland Securities | $14.00 | $8.21 | StreetInsider | Northland Starts Cardlytics (CDLX) at Outperform |
| April 9, 2024 6:38 am | Kyle Peterson | Needham | $17.00 | $14.01 | StreetInsider | Cardlytics (CDLX) PT Raised to $17 at Needham |
Latest News for CDLX
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improving every single month of the quarter,” said Amit Gupta, CEO of Cardlytics. “We added new…
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022…
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted…
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for CDLX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.